SEI Investments
BDSX icon

SEI Investments’s Biodesix BDSX Stock Holding History

SEI Investments’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Sell
37,295
-5,729
-13% -$84.9K ﹤0.01% 2394
2026
Q1 		$624K Buy
+43,024
New +$533K ﹤0.01% 2578

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SEI Investments's BDSX Position: Q2 2026 in Review

SEI Investments reduced its Biodesix (BDSX) stake by 13% in Q2 2026, selling an estimated $84.9K and leaving 37,295 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

SEI Investments first reported a position in BDSX in Q1 2026 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • SEI Investments held 37,295 shares of Biodesix worth $841K as of Q2 2026.
  • SEI Investments sold 5,729 Biodesix shares in Q2 2026, an estimated $84.9K.
  • Biodesix made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2394 holding.
  • SEI Investments first reported a position in Biodesix in Q1 2026 and has held it in 2 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.